抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Ocrelizumab
All
TD-HY257026_1.jpg
TD-HY257026_2.jpg
TD-HY257026_3.jpg
- Catalog： TD-HY257026
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： 2H7,PR-070769/PR070769/R-1594/RG-1594,CAS:637334-45-3
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Ocrelizumab
| Catalog No. | TD-HY257026 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-nd |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P11836 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | 2H7,PR-070769/PR070769/R-1594/RG-1594,CAS:637334-45-3 |
| Background | Ocrelizumab (Ocrevus) is a humanized anti-CD20 monoclonal antibody. Ocrelizumab can induce B cell depletion and inhibit multiple sclerosis lesions in mice through antibody dependent cytotoxicity (ADCC). |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Ocrelizumab. |
|
|
Detects Human CD20/MS4A1 in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Ocrelizumab. |